In prior work, a quantitative benefit–risk analysis approach, building on the FDA’s qualitative approach, was described 14 and used for analysis of regulatory decision making in new drug applications ...
The FAO and the WHO have put out draft guidance on microbiological risk assessment for food for public comment. It is intended to provide guidance and a framework for carrying out each of the four ...